e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
N-acetylcysteine reduces tumor necrosis factor-α release by alveolar macrophages of interstitial lung disease
in vitro
Q. Ye, A. Cui, J. Guzman, U. Costabel (Essen, Bochum, Germany)
Source:
Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Session:
Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Session type:
Thematic Poster Session
Number:
776
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Q. Ye, A. Cui, J. Guzman, U. Costabel (Essen, Bochum, Germany). N-acetylcysteine reduces tumor necrosis factor-α release by alveolar macrophages of interstitial lung disease
in vitro
. Eur Respir J 2007; 30: Suppl. 51, 776
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease
Source: Eur Respir J 2006 Oct 01;28(4):824-831
Year: 2006
Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction
Source: Eur Respir J 2012; 40: 424-435
Year: 2012
Comparison of the capacity of beta-2-stimulants and tumor necrosis factor to resorb alveolar fluid in rat lung
Source: Eur Respir J 2002; 20: Suppl. 38, 488s
Year: 2002
Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis
Source: Eur Respir J 2003; 21: 421-428
Year: 2003
CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages
Source: Eur Respir J, 51 (3) 1702120; 10.1183/13993003.02120-2017
Year: 2018
Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages
in vitro
Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research
Year: 2005
Preferential activation of alveolar macrophages versus epithelial cells during initiation of ventilator-induced lung injury in mice
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages
Source: Eur Respir J 2006; 28: 486-495
Year: 2006
Activation of alveolar fluid reabsorption in rat lung by tumor necrosis factor and terbutaline is triggered by different mechanisms
Source: Eur Respir J 2004; 24: Suppl. 48, 452s
Year: 2004
Co-culturing alveolar epithelial with lung micro-vascular endothelial cells attenuates hypoxia-induced alveolar leakage and inhibition of reabsorption
Source: Annual Congress 2009 - Crossing the line: alveolo-capillary barrier control in acute lung injury
Year: 2009
Fas-mediated lung injury is independent of resident alveolar macrophages
Source: Eur Respir J 2007; 30: Suppl. 51, 444s
Year: 2007
Increased SDF-1alpha production from alveolar macrophages in sarcoidosis in vitro
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008
Role of alveolar macrophages in acute lung injury model
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Influence of depletion of alveolar macrophages by 2-chloroadenosine inhalation on apoptosis in candida-induced acute lung injury
Source: Eur Respir J 2002; 20: Suppl. 38, 488s
Year: 2002
Paraquat induced damage in rat lung epithelial cells and alveolar macrophages
Source: Eur Respir J 2001; 18: Suppl. 33, 79s
Year: 2001
Phenotipic diferences between alveolar and interstitial macrophages in acute lung injury induced by pancreatitis
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD)
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Impaired lung neutrophil clearance causes necrosis and enhanced inflammation
Source: Eur Respir J 2004; 24: Suppl. 48, 452s
Year: 2004
Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept